SILVER END SURGERY — All Prescriptions & Medications — Page 4
Practice Code: Y05023 | WITHAM, CM8 3RQ
Showing results 151-200 of 464
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Oxycodone hydrochloride | 118 | 23.8K | £2.6K | -53.9% ▼ |
| Mesalazine (Systemic) | 117 | 13.5K | £6.1K | -51.2% ▼ |
| Hyoscine butylbromide | 116 | 5,248 | £463 | -50.2% ▼ |
| Loperamide hydrochloride | 114 | 8,606 | £183 | -51.1% ▼ |
| Clobetasone butyrate | 114 | 4,520 | £891 | -44.1% ▼ |
| Phenoxymethylpenicillin (Penicillin V) | 112 | 10.9K | £442 | -63.5% ▼ |
| Digoxin | 110 | 3,252 | £237 | -70.9% ▼ |
| Linagliptin | 108 | 3,108 | £3.5K | -73.6% ▼ |
| Edoxaban | 107 | 3,089 | £5.1K | -84.7% ▼ |
| Lorazepam | 107 | 3,331 | £824 | -24.9% ▼ |
| BeclometDiprop/Formoterol/Glycopyrronium (Corticosteroids) | 105 | 105 | £4.7K | -37.2% ▼ |
| Glyceryl trinitrate | 104 | 797 | £289 | -56.0% ▼ |
| Etoricoxib | 102 | 2,912 | £751 | +26.6% ▲ |
| Rizatriptan | 101 | 971 | £3.2K | +69.9% ▲ |
| Budesonide | 100 | 135 | £3.2K | -81.5% ▼ |
| Biphasic isophane insulin | 100 | 589 | £2.5K | -10.4% ▼ |
| Docusate sodium | 99 | 18.6K | £1.1K | -73.3% ▼ |
| Perindopril erbumine | 99 | 2,963 | £244 | -81.3% ▼ |
| Loratadine | 99 | 6,117 | £172 | -52.6% ▼ |
| Medroxyprogesterone acetate | 99 | 101 | £580 | -18.0% ▼ |
| Hydroxychloroquine sulfate | 99 | 5,306 | £402 | -48.9% ▼ |
| Sacubitril/valsartan | 97 | 5,656 | £9.2K | -59.5% ▼ |
| Timolol and bimatoprost | 97 | 918 | £1.0K | -36.1% ▼ |
| Lisdexamfetamine dimesylate | 96 | 2,688 | £6.3K | -19.6% ▼ |
| Dihydrocodeine tartrate | 95 | 11.5K | £712 | -51.4% ▼ |
| Chloramphenicol | 95 | 698 | £451 | -17.0% ▼ |
| Dexamethasone | 95 | 525 | £327 | -44.8% ▼ |
| Cyanocobalamin | 94 | 4,480 | £446 | -73.4% ▼ |
| Powder extensively hydrolysed formula (0913101) | 93 | 213.6K | £5.9K | +29.1% ▲ |
| 93 | 42.5K | £507 | -64.7% ▼ | |
| Umeclidinium bromide/vilanterol | 91 | 96 | £3.0K | -53.3% ▼ |
| RtS 2-2.4 kcal/ml m/sk higher protein,higher energy(0913011) | 91 | 866.8K | £8.5K | +108.0% ▲ |
| Rivastigmine | 90 | 2,902 | £3.8K | +30.8% ▲ |
| Bumetanide | 89 | 3,220 | £311 | -67.3% ▼ |
| Cefalexin | 89 | 3,893 | £252 | -23.5% ▼ |
| Topiramate | 88 | 5,266 | £679 | -50.5% ▼ |
| Lymecycline | 88 | 1,970 | £231 | -26.8% ▼ |
| 83 | 812 | £287 | -66.7% ▼ | |
| Nystatin | 82 | 2,520 | £145 | -18.7% ▼ |
| Umeclidinium bromide | 81 | 88 | £2.3K | +31.4% ▲ |
| Pramipexole | 80 | 5,924 | £3.7K | -18.5% ▼ |
| Estriol | 80 | 1,513 | £795 | -62.4% ▼ |
| Quinine sulfate | 79 | 2,408 | £368 | -72.7% ▼ |
| Estradiol | 78 | 1,896 | £902 | -71.1% ▼ |
| Donepezil hydrochloride | 77 | 2,660 | £104 | -75.0% ▼ |
| Brinzolamide | 76 | 425 | £307 | -41.5% ▼ |
| Bimatoprost | 76 | 459 | £543 | -48.9% ▼ |
| Insulin degludec | 75 | 472 | £5.7K | -31.8% ▼ |
| Thiamine hydrochloride | 74 | 4,376 | £117 | -86.0% ▼ |
| Dulaglutide | 73 | 304 | £5.6K | -36.3% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.